These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24728601)

  • 1. [Pharmacogenic osteoporosis beyond cortisone. Proton pump inhibitors, glitazones and diuretics].
    Kann PH; Hadji P; Bergmann RS
    Z Rheumatol; 2014 May; 73(4):323-8. PubMed ID: 24728601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fracture risk associated with drugs other than glucocorticoids].
    Okazaki R
    Clin Calcium; 2014 Mar; 24(3):357-65. PubMed ID: 24576932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Metabolic bone disease and fracture induced by drugs].
    Suzuki H
    Clin Calcium; 2013 Sep; 23(9):1307-12. PubMed ID: 23999367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term proton pump inhibitor therapy and osteoporosis. Is there a real danger?].
    Maléth J; Hegyi P
    Orv Hetil; 2013 Jun; 154(26):1005-9. PubMed ID: 23800385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of proton pump inhibitors and risk of osteoporosis-related fractures.
    Targownik LE; Lix LM; Metge CJ; Prior HJ; Leung S; Leslie WD
    CMAJ; 2008 Aug; 179(4):319-26. PubMed ID: 18695179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
    Lin SM; Yang SH; Liang CC; Huang HK
    Osteoporos Int; 2018 Jan; 29(1):153-162. PubMed ID: 29032384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced osteoporosis: mechanisms and clinical implications.
    Mazziotti G; Canalis E; Giustina A
    Am J Med; 2010 Oct; 123(10):877-84. PubMed ID: 20920685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug-induced osteoporosis].
    Briot K
    Rev Prat; 2012 Feb; 62(2):187-92. PubMed ID: 22408857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitors and osteoporosis.
    Andersen BN; Johansen PB; Abrahamsen B
    Curr Opin Rheumatol; 2016 Jul; 28(4):420-5. PubMed ID: 27224743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors, osteoporosis, and osteoporosis-related fractures.
    Fournier MR; Targownik LE; Leslie WD
    Maturitas; 2009 Sep; 64(1):9-13. PubMed ID: 19674854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies.
    Poly TN; Islam MM; Yang HC; Wu CC; Li YJ
    Osteoporos Int; 2019 Jan; 30(1):103-114. PubMed ID: 30539272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced osteoporosis: from Fuller Albright to aromatase inhibitors.
    Byreddy DV; Bouchonville MF; Lewiecki EM
    Climacteric; 2015; 18 Suppl 2():39-46. PubMed ID: 26488130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of cortisone-induced osteoporosis].
    Trombetti A; Ferrari S; Stoermann-Chopard C; Rizzoli R
    Praxis (Bern 1994); 2004 Mar; 93(11):407-14. PubMed ID: 15061108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitor therapy and osteoporosis.
    Yang YX
    Curr Drug Saf; 2008 Sep; 3(3):204-9. PubMed ID: 18691003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton Pump Inhibitors and Bone Health: What the Orthopaedic Surgeon Needs to Know.
    Wagner SC
    JBJS Rev; 2018 Dec; 6(12):e6. PubMed ID: 30562209
    [No Abstract]   [Full Text] [Related]  

  • 16. Proton Pump Inhibitors and Osteoporosis: Is Collagen a Direct Target?
    Ghebre YT
    Front Endocrinol (Lausanne); 2020; 11():473. PubMed ID: 32793122
    [No Abstract]   [Full Text] [Related]  

  • 17. Association between diuretic use and the risk of vertebral fracture after stroke: a population-based retrospective cohort study.
    Lin SM; Yang SH; Wang CY; Huang HK
    BMC Musculoskelet Disord; 2019 Mar; 20(1):96. PubMed ID: 30832635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic use of proton pump inhibitors: is the risk of osteoporosis and fractures real?].
    Martí-Cabrera M; Martí-Masanet M; Esplugues JV
    Gastroenterol Hepatol; 2011 Apr; 34(4):271-7. PubMed ID: 21419526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced bone loss: a major safety concern in Europe.
    Nguyen KD; Bagheri B; Bagheri H
    Expert Opin Drug Saf; 2018 Oct; 17(10):1005-1014. PubMed ID: 30222369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies.
    Yu EW; Bauer SR; Bain PA; Bauer DC
    Am J Med; 2011 Jun; 124(6):519-26. PubMed ID: 21605729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.